PharmaCyte Biotech, Inc. PMCB
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.72% | 80.56% | 31.59% | 16.12% | -13.50% |
| Total Receivables | 78.24% | -- | -- | 8.51% | 24.68% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -66.98% | -38.94% | -68.46% | 111.21% | 6.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 133.17% | -71.89% |
| Total Current Assets | -17.23% | 80.81% | -10.10% | 20.50% | -14.61% |
|
|
|||||
| Total Current Assets | -17.23% | 80.81% | -10.10% | 20.50% | -14.61% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -38.52% | -16.34% | 4.67% | 121.13% | -45.04% |
| Total Assets | -21.48% | -16.32% | -0.18% | 24.09% | -18.23% |
|
|
|||||
| Total Accounts Payable | 44.04% | -77.41% | 17.51% | 119.54% | 16.53% |
| Total Accrued Expenses | -30.55% | 44.00% | 0.00% | 0.00% | -33.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -43.48% | -56.60% | -37.02% | -15.84% | -87.46% |
| Total Other Current Liabilities | -43.48% | -56.60% | -37.02% | -15.84% | -87.46% |
| Total Current Liabilities | -6.98% | -50.76% | 6.39% | 48.69% | -63.60% |
|
|
|||||
| Total Current Liabilities | -6.98% | -50.76% | 6.39% | 48.69% | -63.60% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -44.02% | -26.01% | -17.10% | 3,796.29% | 26.17% |
| Total Liabilities | -41.42% | -28.53% | -15.19% | 1,178.71% | -53.65% |
|
|
|||||
| Common Stock & APIC | -0.39% | -0.23% | 1.40% | -0.52% | 0.03% |
| Retained Earnings | -4.87% | -4.39% | 0.74% | -7.95% | -9.84% |
| Treasury Stock & Other | 0.00% | 0.00% | -0.90% | 0.93% | 0.00% |
| Total Common Equity | -17.16% | -12.50% | 8.07% | -18.21% | -15.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 48.96% | 45.47% | -3.29% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 48.96% | 45.47% | -3.29% | -- | -- |
|
|
|||||
| Total Common Equity | -17.16% | -12.50% | 8.07% | -18.21% | -15.99% |
| Total Preferred Equity | 48.96% | 45.47% | -3.29% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.77% | -11.22% | 7.79% | -16.14% | -15.99% |
|
|
|||||